Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Epigallocatechin- 3- gallate
Most Correlated Studies
- Epigallocatechin-3-gallate (EGCG)-induced neuronal death
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
Most Relevant Literature
- Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea.
- Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for e…
- Novel epigallocatechin gallate analogs as potential anticancer agents: a patent review (2009 - prese…
- Electroanalysis of the interaction between (-)-epigallocatechin-3-gallate (EGCG) and amyloid-β in th…
- Epigallocatechin-3-gallate inhibits voltage-gated proton currents in BV2 microglial cells.
Most Relevant Clinical Trials
- Effect of Epigallocatechin -3-gallate Supplementation in Traumatic Brain Injury Patients
- Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)
- A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-g…
- Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients
- Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients Wit…
